Pathology referred testing 2026

Description

This procurement exercise is to complete the award of multiple Pathology referred testing contracts to various suppliers, via the Provider Selection Regime's (PSR) most suitable provider process (MSP). <br/><br/>This award will be for a total of 36 months (3 years) with each provider, the total value across both NHS Trusts is £2,852,768.49 (Excluding VAT). <br/><br/>The contractual dates for these agreements are the 1st April 2026 - 31st March 2029. Lot 1: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 4th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>Any written representations should be sent to matthew.povey@nhs.net , before the above mentioned date. <br/><br/>Conflicts of interest identified among internal stakeholders : [0] Additional information: Selected suppliers per Trust.<br/><br/>North Tees & Hartlepool NHS FT are awarding to:<br/><br/>Alder Hey Children's NHS FT<br/>Barts Health NHS FT                                                          <br/>Belfast Health and Social care Trust<br/>Black Country Pathology Services (The Royal Wolverhampton)<br/>Cardiff and Vale ULHB<br/>CDDFT<br/>Epilepsy Society<br/>Gateshead NHS FT<br/>Gloucestershire Hospital NHS FT<br/>Greater Glasgow and Clyde NHS<br/>Imperial College Projects Ltd<br/>Lothian NHS<br/>Manchester Universities NHS FT<br/>NHS Blood and Transplant<br/>North Bristol NHS Trust<br/>Oxford University Hospital NHS FT<br/>Sheffield Teaching Hospitals NHS FT<br/>Synnovis Analytics LLP<br/>The Christie Pathology Partnership<br/>The Royal Marsden NHS FT<br/>The Royal Wolverhampton NHS FT (Black Country Pathology)<br/>UK Health Security Agency<br/>University College London <br/>University College London Hospitals NHS FT<br/>University Hospitals of Birmingham NHS<br/>York and Scarborough Teaching Hospitals NHS FT<br/><br/>Total estimated value per annum £253,365.83 (ex VAT).<br/><br/>South Tees NHS FT are awarding to:<br/><br/>Barts and London NHS FT<br/>Cambridge Clinical Laboratory<br/>Cambridge University Hospitals NHS<br/>Cardiff and Vale ULHB<br/>Epilepsy Society<br/>Gloucestershire Hospitals NHS <br/>Greater Glasgow and Clyde NHS<br/>HSL Pathology Ltd<br/>Imperial College Healthcare NHS FT<br/>Imperial College Projects Ltd<br/>Manchester University NHS FT<br/>North Bristol NHS <br/>North Cumbria Integrated Care Nhs Ft<br/>Oxford NHS FT<br/>Public Health Wales<br/>Royal Devon and Exeter<br/>Royal Marsden NHS FT<br/>Sheffield Teaching Hospitals NHS FT<br/>Synnovis<br/>UK Health Security Agency<br/>University College London Hospitals<br/>University College of Liverpool Hospital<br/>University Hospitals of Birmingham NHS<br/>York Teaching Hospitals NHS<br/><br/>Total estimated value per annum £697,557.00 (ex VAT).